Mercado de neuromodulación: mapeo competitivo y perspectivas estratégicas 2031

  • Report Code : TIPHE100001415
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 195
Buy Now

El mercado de la Neuromodulación fue valorado en US$ 7.613,45 millones en 2019 y se proyecta que alcance los US$ 16.333,98 millones en 2027; se espera que crezca a una tasa compuesta anual del 10,3 % durante 2020-2027.

Los trastornos neurológicos como las enfermedades cerebrovasculares, la enfermedad de Alzheimer y la enfermedad de Parkinson pueden tratarse con la ayuda de la neuromodulación que se realiza mediante el uso de varios dispositivos o la infusión de medicamentos. Los dispositivos utilizados en el mercado de la neuromodulación implican la aplicación de electrodos a la médula espinal, el cerebro o los nervios periféricos.

regiones lucrativas en el mercado de la neuromodulación

Perspectivas del mercado

La creciente incidencia de trastornos neurológicos impulsa el crecimiento del mercado

La depresión es el trastorno neurológico más común entre todos los grupos de edad. En las regiones en desarrollo, la mayoría de la gente sufre depresión debido a diversos factores socioeconómicos, como el estrés financiero y la pobreza. Otros trastornos neurológicos como la distonía, la enfermedad de Parkinson y el trastorno obsesivo-compulsivo suelen observarse en la población que envejece. Según un estudio "Incidencia y prevalencia de trastornos neurológicos mayores", publicado en enero de 2018, ~36% de las personas mayores tienen un deterioro de la memoria moderado o grave en los EE. UU. Cada año, casi 1,2 millones de adultos son diagnosticados con trastornos cerebrales, de los cuales el 51,3% se debe a un accidente cerebrovascular y el 21% a la enfermedad de Alzheimer. Además, cada año a casi 135 millones de personas se les diagnostica la enfermedad de Parkinson, lesión cerebral traumática y epilepsia. Además, cada año se notifican alrededor de 500 000 casos de tumores cerebrales, esclerosis múltiple y esclerosis lateral amiotrófica. Por lo tanto, la creciente prevalencia de trastornos neurológicos está impulsando la demanda de neuromoduladores, ya que ayudan a aliviar los síntomas neurológicos. Además, la creciente demanda de dispositivos de neuroestimulación para tratar el dolor crónico.

Información sobre los productos

En términos de tecnología, el externo (no invasivo) El segmento de neuromodulación tuvo una mayor participación en el mercado de neuromodulación en 2019. Se espera que el mismo segmento continúe su dominio y registre una CAGR más alta en el mercado durante el período de pronóstico.

Mercado de neuromodulación, por tecnología: 2019 y 2027

Información sobre aplicaciones

Según la aplicación, el mercado global de neuromodulación se segmenta en manejo del dolor crónico, síndrome de espalda fallida, epilepsia, temblor, incontinencia, depresión, distonía, gastroparesia, enfermedad de Parkinson, trastorno obsesivo-compulsivo y migraña. El segmento de manejo del dolor crónico tuvo la mayor participación de mercado en 2019 y se espera que registre la CAGR más alta durante el período de pronóstico.

El manejo del dolor crónico ayuda a aliviar el dolor con el uso de medicamentos, terapias y cambios en el estilo de vida. Los dispositivos de estimulación eléctrica desempeñan un papel importante en el tratamiento del dolor, ya que se desarrollan principalmente para aliviar varios tipos de dolor crónico y agudo. La creciente población geriátrica, el aumento de la prevalencia de enfermedades crónicas y el estilo de vida sedentario son algunos de los factores de riesgo que pueden causar dolor crónico. Por ejemplo, según un estudio publicado por la Arthritis Foundation en 2019, el envejecimiento de la población es responsable de la creciente prevalencia de todo tipo de enfermedades en todo el mundo. El mismo estudio afirmó que 1 de cada 3 personas en los EE. UU. sufre de artritis cada año. Por lo tanto, se espera que la creciente prevalencia del dolor crónico impulse el crecimiento del segmento durante el período de pronóstico.

La incorporación de tecnologías avanzadas en dispositivos de estimulación eléctrica permite beneficios adicionales para el manejo del dolor. Por ejemplo, en enero de 2019, Abbott anunció los resultados de las pruebas de estimulación BurstDR desarrollada para el tratamiento del dolor crónico. Los resultados muestran que el producto reduce el dolor entre un 60% y un 70%.

Información estratégica

Los actores que operan en el mercado de la neuromodulación adoptan estrategias de colaboración y asociación para satisfacer las demandas de los usuarios finales mediante la introducción de ofertas tecnológicamente avanzadas, y estas estrategias apoyan significativamente el crecimiento del mercado.

Por tecnología

  • Neuromodulación externa (no invasiva)
    • Estimulación eléctrica respiratoria
    • Estimulación nerviosa eléctrica transcutánea
    • Estimulación magnética transcraneal
    • Neuromodulación interna
      • Estimulación cerebral profunda
      • Estimulación del nervio sacro
      • Estimulación eléctrica gástrica
      • Estimulación de la médula espinal
      • Estimulación del nervio vago

    Por aplicación

    • Manejo del dolor crónico
    • Síndrome de retroceso
    • Epilepsia
    • Temblor
    • Incontinencia
    • Depresión
    • Distonía
    • Gastroparesia
    • Enfermedad de Parkinson
    • Trastorno obsesivo-compulsivo
    • Migraña
    Por usuario final
    • Hospitales
    • Clínicas
    • Atención médica domiciliaria

    Por geografía

    • América del Norte
        < li>Estados Unidos
      • Canadá
      • México
    • Europa
      • Francia
      • Alemania
      • Italia
      • Reino Unido
      • Rusia
    • Asia Pacífico
      • China
      • India
      • Corea del Sur
      • Japón
      • Australia
    • Oriente Medio y África
      • Sudáfrica
      • Arabia Saudita
      • EAU
    • América del Sur y Central
      • Brasil
      • Argentina

    Perfiles de empresas

    • Abbott
    • Boston Scientific Corporation
    • Medtronic
    • NeuroPace, Inc.
    • NeuroSigma, Inc.
    • NEVRO CORP.
    • Synapse Biomedical Inc.
    • Soterix Medical Inc
    • Integer Holdings Corporation
    • Magstim < /li>
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the neuromodulation?

Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.

What are the driving factors for the neuromodulation market across the globe?

The global neuromodulation market is being driven by factors such as increasing incidence of neurological disorders, growing developments in neuromodulation technology. Furthermore, rising demand for neurostimulation devices to treat chronic pain is likely to offer significant opportunities for the growth of the global neurostimulation market.

What are the restraining factors for the neuromodulation market across the globe?

The high cost of neuromodulation devices is the significant factor that will hinder the neuromodulation market growth.

The List of Companies - Neuromodulation Market

  1. Abbott
  2. Boston Scientific Corporation
  3. Medtronic
  4. NeuroPace, Inc.
  5. NeuroSigma, Inc.
  6. NEVRO CORP.
  7. Synapse Biomedical Inc.
  8. Soterix Medical Inc
  9. Integer Holdings Corporation
  10. Magstim

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports